Do approved blood substitutes reduce myocardial infarction size: Is this the critical question?

British Journal of Anaesthesia

Volumn 103, Issue 4, 2009, Pages 470-471

  Jahr, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN GLUTAMER 200; HEMOSPAN; POLYMERIZED HEMOGLOBIN; UNCLASSIFIED DRUG; HEMOGLOBIN GLUTAMER-200;

ANEMIA; DRUG EFFECT; DRUG SAFETY; EDITORIAL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION; ANIMAL; CATTLE; DISEASE MODEL; METHODOLOGY; NOTE; PATHOLOGY; RABBIT;

ANIMALS; BLOOD SUBSTITUTES; CATTLE; DISEASE MODELS, ANIMAL; HEMOGLOBINS; HUMANS; MYOCARDIAL INFARCTION; RABBITS; RESEARCH DESIGN;

EID: 70350441677     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep227     Document Type: Editorial

References (8)

1. Winslow RM. Alpha alpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang 2000; 79: 1-20
2. Driessen B, Jahr JS, Lurie F, Griffey SM, Gunther RA. Effects of haemoglobin-based oxygen carrier hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model. Br J Anaesth 2001; 86: 683-692
3. Standl T, Horn P, Wilhelm S, et al. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can J Anaesth 1996; 43: 714-723
4. Driessen B, Jahr JS, Lurie F, Golkaryeh M, Gunther RA. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study. Crit Care Med 2003; 31: 1771-1779
5. Driessen B, Zarucco L, Gunther RA, et al. Effects of low volume hemoglobin glutamer-200(bovine) versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model. Crit Care Med 2007; 35: 2101-2109
6. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. J Am Med Assoc 2008; 299: 2304-2312
7. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008; 64: 1484-1497
8. Rempf C, Standl T, Schenke K, et al. Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits. Br J Anaesth 2009; 103: 496-504